ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973

NCI CTEP Approved Trials For the Month of February

February 22, 2013

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011